Free Trial
NYSE:RBOT

Vicarious Surgical (RBOT) Stock Price, News & Analysis

Vicarious Surgical logo
$9.56 +0.53 (+5.87%)
(As of 02:20 PM ET)

About Vicarious Surgical Stock (NYSE:RBOT)

Key Stats

Today's Range
$9.15
$10.45
50-Day Range
$5.32
$11.15
52-Week Range
$4.27
$21.43
Volume
20,221 shs
Average Volume
25,839 shs
Market Capitalization
$56.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.25
Consensus Rating
Hold

Company Overview

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Vicarious Surgical Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
41st Percentile Overall Score

RBOT MarketRank™: 

Vicarious Surgical scored higher than 41% of companies evaluated by MarketBeat, and ranked 686th out of 952 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Vicarious Surgical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Vicarious Surgical has only been the subject of 1 research reports in the past 90 days.

  • Read more about Vicarious Surgical's stock forecast and price target.
  • Earnings Growth

    Earnings for Vicarious Surgical are expected to grow in the coming year, from ($10.89) to ($9.66) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vicarious Surgical is -0.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vicarious Surgical is -0.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Vicarious Surgical has a P/B Ratio of 0.94. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Vicarious Surgical's valuation and earnings.
  • Percentage of Shares Shorted

    1.12% of the outstanding shares of Vicarious Surgical have been sold short.
  • Short Interest Ratio / Days to Cover

    Vicarious Surgical has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vicarious Surgical has recently decreased by 28.94%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Vicarious Surgical does not currently pay a dividend.

  • Dividend Growth

    Vicarious Surgical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.12% of the outstanding shares of Vicarious Surgical have been sold short.
  • Short Interest Ratio / Days to Cover

    Vicarious Surgical has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vicarious Surgical has recently decreased by 28.94%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Vicarious Surgical has a news sentiment score of -0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Vicarious Surgical this week, compared to 1 article on an average week.
  • Search Interest

    Only 2 people have searched for RBOT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Vicarious Surgical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,402.00 in company stock.

  • Percentage Held by Insiders

    11.73% of the stock of Vicarious Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    47.27% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Vicarious Surgical's insider trading history.
Receive RBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter.

RBOT Stock News Headlines

Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share
The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.
See More Headlines

RBOT Stock Analysis - Frequently Asked Questions

Vicarious Surgical's stock was trading at $11.0010 at the beginning of the year. Since then, RBOT stock has decreased by 16.4% and is now trading at $9.20.
View the best growth stocks for 2024 here
.

Vicarious Surgical Inc (NYSE:RBOT) issued its earnings results on Monday, March, 4th. The company reported ($2.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($3.60) by $1.50.

Vicarious Surgical's stock reverse split on Thursday, June 13th 2024. The 1-30 reverse split was announced on Thursday, June 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 13th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vicarious Surgical investors own include NVIDIA (NVDA), Akoustis Technologies (AKTS), Advanced Micro Devices (AMD), Palantir Technologies (PLTR), PayPal (PYPL), Taiwan Semiconductor Manufacturing (TSM) and SoFi Technologies (SOFI).

Company Calendar

Last Earnings
3/04/2024
Today
11/21/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
3/03/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.25
High Stock Price Target
$10.50
Low Stock Price Target
$10.00
Potential Upside/Downside
+7.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-71,070,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$9.81 per share

Miscellaneous

Free Float
5,205,000
Market Cap
$56.52 million
Optionable
Optionable
Beta
1.02
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NYSE:RBOT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners